相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Wickerhamomyces anomalus in Mosquitoes: A Promising Yeast-Based Tool for the Symbiotic Control of Mosquito-Borne Diseases
Alessia Cappelli et al.
FRONTIERS IN MICROBIOLOGY (2021)
Anti-Infective Antibody-Derived Peptides Active against Endogenous and Exogenous Fungi
Tecla Ciociola et al.
MICROORGANISMS (2021)
In Vitro and In Vivo Anti-Candida Activity and Structural Analysis of Killer Peptide (KP)-Derivatives
Tecla Ciociola et al.
JOURNAL OF FUNGI (2021)
Antibiotic Activity of Wickerhamomyces anomalus Mycocins on Multidrug-Resistant Acinetobacter baumannii
Daniele S. B. Junges et al.
MICROBIAL ECOLOGY (2020)
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion
Luca Ferrari et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2020)
Yeast killer toxins: from ecological significance to application
Ilaria Mannazzu et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2019)
The ecology of killer yeasts: Interference competition in natural habitats
Primrose J. Boynton
YEAST (2019)
Three dimensional structure prediction of panomycocin, a novel Exo-β-1,3-glucanase isolated from Wickerhamomyces anomalus NCYC 434 and the computational site-directed mutagenesis studies to enhance its thermal stability for therapeutic applications
Muhammed Tilahun Muhammed et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Killer yeasts exert anti-plasmodial activities against the malaria parasite Plasmodium berghei in the vector mosquito Anopheles stephensi and in mice
Alessia Cappelli et al.
PARASITES & VECTORS (2019)
Identification of a Killer Toxin from Wickerhamomyces anomalus with β-Glucanase Activity
Valentina Cecarini et al.
TOXINS (2019)
Candidacidal Activity of a Novel Killer Toxin from Wickerhamomyces anomalus against Fluconazole-Susceptible and -Resistant Strains
Laura Giovati et al.
TOXINS (2018)
Novel Activity of a Synthetic Decapeptide Against Toxoplasma gondii Tachyzoites
Laura Giovati et al.
FRONTIERS IN MICROBIOLOGY (2018)
Isolation of a Wickerhamomyces anomalus yeast strain from the sandfly Phlebotomus perniciosus, displaying the killer phenotype
E. Martin et al.
MEDICAL AND VETERINARY ENTOMOLOGY (2016)
Susceptibility of Candida albicans Isolated from Blood to Wickerhamomyces anomalous Mycocins
Ana Paula Paris et al.
CURRENT MICROBIOLOGY (2016)
A yeast strain associated to Anopheles mosquitoes produces a toxin able to kill malaria parasites
Matteo Valzano et al.
MALARIA JOURNAL (2016)
Antibodies as a source of anti-infective peptides: an update
Walter Magliani et al.
FUTURE MICROBIOLOGY (2015)
Yeast killer toxins, molecular mechanisms of their action and their applications
Guang-Lei Liu et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
Growth inhibition of Candida species by Wickerhamomyces anomalus mycocin and a lactone compound of Aureobasidium pullulans
Sun-Tee Tay et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
A Wickerhamomyces anomalus Killer Strain in the Malaria Vector Anopheles stephensi
Alessia Cappelli et al.
PLOS ONE (2014)
A novel killer toxin produced by the marine-derived yeast Wickerhamomyces anomalus YF07b
Feng-Jun Guo et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2013)
Bacteriocins - a viable alternative to antibiotics?
Paul D. Cotter et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Identification and Partial Characterization of Antilisterial Compounds Produced by Dairy Yeasts
Rima Hatoum et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2013)
CHARACTERIZATION OF TWO DIFFERENT TOXINS OF WICKERHAMOMYCES ANOMALUS (PICHIA ANOMALA) VKM Y-159
Z. Farkas et al.
ACTA BIOLOGICA HUNGARICA (2012)
Antibacterial Peptides “Bacteriocins”: An Overview of Their Diverse Characteristics and Applications
MAMI NISHIE et al.
BIOCONTROL SCIENCE (2012)
Genome sequence of Wickerhamomyces anomalus DSM 6766 reveals genetic basis of biotechnologically important antimicrobial activities
Jessica Schneider et al.
FEMS YEAST RESEARCH (2012)
Antibody peptide based antifungal immunotherapy
Walter Magliani et al.
FRONTIERS IN MICROBIOLOGY (2012)
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy
Luciano Polonelli et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Different mosquito species host Wickerhamomyces anomalus (Pichia anomala): perspectives on vector-borne diseases symbiotic control
Irene Ricci et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Pichia anomala: cell physiology and biotechnology relative to other yeasts
Graeme M. Walker
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Safety and regulation of yeasts used for biocontrol or biopreservation in the food or feed chain
Ingvar Sundh et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Past, present and future research directions with Pichia anomala
Volkmar Passoth et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Phylogeny of the ascomycetous yeasts and the renaming of Pichia anomala to Wickerhamomyces anomalus
Cletus P. Kurtzman
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2011)
Antifungal Activity of Wickerhamomyces anomalus and Lactobacillus plantarum during Sourdough Fermentation: Identification of Novel Compounds and Long-Term Effect during Storage of Wheat Bread
Rossana Coda et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide
M. Enamul Kabir et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs
Walter Magliani et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Pichia anomala DBVPG 3003 Secretes a Ubiquitin-Like Protein That Has Antimicrobial Activity
Jessica De Ingeniis et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
From yeast killer toxins to antibiobodies and beyond
Walter Magliani et al.
FEMS MICROBIOLOGY LETTERS (2008)
Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov and Wickerhamomyces gen. nov.
Cletus P. Kurtzman et al.
FEMS YEAST RESEARCH (2008)
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies
Walter Magliani et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
An anti-β-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofonnans in vitro and exerts therapeutic, anticryptococcal activity in vivo
Anna Rachini et al.
INFECTION AND IMMUNITY (2007)
Inhibition of fungal β-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies
Dakshnamurthy Selvakumar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Killer toxin of Pichia anomala NCYC 432;: purification, characterization and its exo-β-1,3-glucanase activity
Fatih Izgu et al.
ENZYME AND MICROBIAL TECHNOLOGY (2006)
Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin
D Selvakumar et al.
JOURNAL OF BIOCHEMISTRY (2006)
Yeast viral killer toxins: lethality and self-protection
MJ Schmitt et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Inhibition of β-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies
D Selvakumar et al.
JOURNAL OF ANTIBIOTICS (2006)
Recombinant single-chain anti-idiotypic antibody: An effective fungal beta-1,3-glucan synthase inhibitor
Dakshnamurthy Selvakumar et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Biotechnology, physiology and genetics of the yeast Pichia anomala
V Passoth et al.
FEMS YEAST RESEARCH (2006)
Enzymic activity of the K5-type yeast killer toxin and its characterization
F Izgü et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2005)
Bacteriocins: Developing innate immunity for food
PD Cotter et al.
NATURE REVIEWS MICROBIOLOGY (2005)
A novel glyco-conjugate vaccine against fungal pathogens
A Torosantucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Isolation and characterization of the K5-type yeast killer protein and its homology with an exo-β-1,3-glucanase
F Izgu et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2004)
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis
L Polonelli et al.
INFECTION AND IMMUNITY (2003)
Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine
C Bromuro et al.
INFECTION AND IMMUNITY (2002)
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria
C Beninati et al.
NATURE BIOTECHNOLOGY (2000)
分享论文
